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The mechanism by which elevated intraocular pressure (IOP) increases risk of glaucoma 
remains unknown. A proposed pathway suggests astrocytes sense optic nerve head (ONH) 
deformation due to increased IOP, triggering their conversion to a reactive phenotype1. When 
reactive, they can promote axonal damage in retinal ganglion cells (RGCs), causing progressive 
vision loss in glaucoma patients4. Most research aimed at understanding astrocyte 
mechanobiology has been conducted in monolayer culture systems using DiTNC1 cells, a brain-
derived line of cells, rather than primary ONH astrocytes13. Such 2D cultures are problematic 
because they induce baseline activation, restricting our ability to understand true cellular 
response to stressors8,9. Based on research using 3D culture systems that yielded preliminary 
results with DiTNC1 cells, we aim to develop a 3D culture system that can be used to elucidate 
astrocyte mechanotransduction pathways using primary ONH astrocytes and contribute to the 
development of accurate in vitro models of glaucoma10,11.  
Characterization of isolated rat ONH astrocytes revealed positive staining for the 
astrocyte markers connexin-43, glial fibrillary acidic protein (GFAP), and vimentin. These 
astrocytes can be used to more accurately model and understand glaucomatous pathology using 
our 3D culture system. With the hope of ultimately developing an “optic nerve head on a chip,” 
our model system will expedite assessment of potential astrocyte-targeted therapeutics, 







 Glaucoma is an optic neuropathy recognized as the principal cause of permanent vision 
loss worldwide. It affects approximately 64 million individuals, a number projected to double in 
the next twenty years2. All current therapies aim to lower IOP, the primary known risk factor for 
glaucoma1. These treatments typically involve a cumbersome regimen comprised of expensive 
medications and multiple eye-drop administrations throughout the day. Americans alone spend 
an estimated $2.9 billion annually to manage their glaucoma3. Combined, these factors can often 
result in poor patient compliance. Additionally, present therapeutics mainly decelerate, not treat 
or reverse, vision loss1. 
In order to formulate more successful treatment options, it is imperative that we better 
understand glaucomatous pathology. Researchers have proposed that optic nerve head 
deformation (ONH), instigated by elevated intraocular pressure (IOP), causes astrocytes to 
transition to a reactive phenotype5,6. Astrocytes are mechanosensitive glial support cells that 
maintain the matrix surrounding RGCs7. When reactive, their altered expression may induce 
axonal degradation in RGCs, prompting progressive vision loss4. However, the role of astrocyte 
activation and reactivity in glaucoma remains unknown. We propose that alteration of matrix 
properties leads to chronic astrocyte reactivity, which has been implicated in glaucoma, but we 
need a physiologically relevant system to be able to interrogate this suggested relationship.  
 We aim to create a high throughput 3D astrocyte culture system that will contribute to the 
development of accurate in vitro models of glaucoma by addressing limitations of previous work 
done to investigate astrocyte mechanobiology. For example, an overwhelming majority of 
astrocyte mechanobiology research has been conducted using 2D monolayer culture systems8. 
These are problematic in vitro models because they induce astrocyte activation in the absence of 
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mechanical stimulation and, therefore, cannot be used to assess the true nature of astrocyte 
reactivity to individual stimuli8,9. The limited research conducted using 3D culture systems has 
yielded comparatively smaller baseline activation levels, making them a better candidate for 
creating in vivo systems10,11. Unlike 2D culture systems, 3D systems can also model the main 
mode of biomechanical strain: compression10,13. Furthermore, most in vitro research exploring 
astrocyte mechanobiology has relied on the use of the commercially available DiTNC1 cell line. 
Although astrocytes, DiTNC1 cells are extracted from the neocortical layer of the brain13 and 
may differ in cellular response and subsequent alteration of the biochemical environment in 
response to mechanical stressors compared to ONH astrocytes. Therefore, we propose to isolate 
astrocytes from the ONH and use them to investigate astrocyte mechanotransduction properties.   
METHODS 
Isolation of Rat ONH cells (Type 1A) - Eyes were enucleated from 3 female CD rats, 
aged 6 months, and the optic nerve head was dissected out and broken down. Tissue was 
digested in 0.1% trypsin/EDTA, then centrifuged to isolate cells from tissue14.  
Cell Culture - Cells were cultured in a growth medium (DMEM, 20% FBS, 1X pen/strep) 
and seeded on poly-L-lysine (PLL) coated coverslips. Coverslips were stored in PBS14.  
Immunohistochemistry- Cells on coverslips were fixed in paraformaldehyde for half an 
hour, then blocked in a blocking solution (10% FBS, 2% sodium azide, and 88% PBS) for an 
hour at room temperature. DiTNC1 cells were used as a positive control. Cells were washed 
twice with the blocking buffer and incubated in primary antibodies diluted in blocking buffer at 
4°C overnight: Connexin-43 (Invitrogen, 1:50), GFAP (Invitrogen, 1:200), and Vimentin (1:200, 
Santa Cruz Biotechnology). Controls were left in blocking buffer. Cells were then washed 3 
times with blocking buffer,  leaving 10 minutes between each wash, and placed in secondary 
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antibody solution consisting of Phalloidin (1:30, Abcam), Alexa Fluor®647 anti-mouse or anti-
rabbit IgG (1:200, Molecular Probes-Invitrogen), and DAPI (3 drops, Molecular Probes) diluted 
in blocking solution for an hour at room temperature in the dark. Controls for both cell types 
were prepared with secondary treatment only. Cells were washed two times with blocking 
solution, leaving 10 minutes between each wash, mounted, and imaged using a Leica DM6 B 
microscope. The same gain settings were used for each set of control and experimental samples 
to ensure consistency and validity when evaluating protein presence.   
RESULTS 
 
Figure 1: Immunofluorescence labeling of DiTNC1 cells. (A, C-D) Immunolabeling for 
connexin-43, GFAP, and vimentin (red), respectively, merged with phalloidin (green) and nuclei 
(blue) staining. (B) Immunolabeling for phalloidin and nuclei only. Positive staining was present 





















Figure 2: Immunofluorescence labeling of primary ONH cells. (A, C-D) Immunolabeling for 
connexin-43, GFAP, and vimentin (red), respectively, merged with phalloidin (green) and nuclei 
(blue) staining. (B) Immunolabeling for phalloidin and nuclei only. Positive staining was present 
for all three astrocyte markers. 
DISCUSSION 
 Positive staining for the three astrocyte markers connexin-43, glial fibrillary acidic 
protein, and vimentin allowed us to verify the cell type. Differences in cell morphology between 
DiTNC1 cells and primary ONH astrocytes suggests that significant differences exist between 
the cell types, which may be important in studies investigating how astrocyte mechanobiology 
impacts progression of glaucoma. The large size of the ONH astrocytes complicates 








heterogeneity of cell stages. Additionally, presence of spheroids in hydrogels may hinder 
mimicry of in vivo vascularization because it is more difficult for substances to move into larger 
spheroids via diffusion, which is the only mode of cell entry in 3D culture systems18.   
CONCLUSIONS & FUTURE WORK  
Now that we have isolated primary ONH astrocytes, we can begin testing of our 3D 
culture system. We will need to verify primary astrocyte viability in the 3D culture system as 
well as analyse the construct for hypoxia. Members of the Ethier lab have developed a bioreactor 
capable of applying uniform cyclic compression to the hydrogels, modelling the main form of 
biomechanical strain that the ONH experiences. Afterwards, the mechanical properties of the 3D 
hydrogel constructs will need to be assessed using unconfined compression testing to ensure the 
matrix environment is mechanically similar to an ONH environment. Once a physiologically 
representative environment in the construct has been confirmed, we can direct efforts towards 
understanding astrocyte responses to mechanical forces. Understanding the pathway will allow 
us to explore compounds that interfere with astrocyte mechanotransduction such as nonselective 
P2 receptor antagonists, which have been shown to impede crucial communication between 
astrocytes and neurons. We can also evaluate mechanically stimulated astrocytes for expression 
of proteins like nestin, tumor necrosis factors, and matrix metalloproteinases that are known to 
play a role in remodelling the extracellular matrix surrounding RGCs 6,15, 16,. Additionally, our 
system will diminish the need for animal subjects to study glaucoma, and serve as a step towards 
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